TY - CHAP M1 - Book, Section TI - Renal Artery Angioplasty and Stenting A1 - White, Christopher J. A1 - Tafur-Soto, Jose David A2 - Samady, Habib A2 - Fearon, William F. A2 - Yeung, Alan C. A2 - King III, Spencer B. Y1 - 2017 N1 - T2 - Interventional Cardiology, 2e AB - Clinical benefit from any revascularization procedure will be the net gain due to reperfusion of the ischemic organ balanced against the risk of a procedural complication. The same is true for renal artery ischemia caused by atherosclerotic or, less commonly, fibromuscular dysplasia (FMD) lesions (Fig. 52-1). Recent clinical trials have attempted to determine the benefit of revascularization but have been seriously hampered by difficulty in defining a threshold for an ischemia producing renal artery stenosis (RAS). SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/28 UR - accesscardiology.mhmedical.com/content.aspx?aid=1146604656 ER -